#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Angiosarcoma Acquired haemophilia Fibrosarcoma metastatic KBG syndrome Small intestine neuroendocrine tumour Malignant glioma Transient ischaemic attack Duchenne muscular dystrophy gene carrier Haemophilia A with anti factor VIII Arterial tortuosity syndrome Cholangitis sclerosing Rhabdomyosarcoma recurrent Familial amyotrophic lateral sclerosis Chronic graft versus host disease Lung adenocarcinoma More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome with excess blasts Langerhans’ cell histiocytosis Chordoma – Basic Information Pelizaeus-Merzbacher disease Idiopathic inflammatory myopathy Congenital nephrogenic diabetes insipidus – Diagnostics Pleomorphic leiomyosarcoma – Basic Information Pelizaeus-Merzbacher disease – Trials in Disease Alagille syndrome – Basic Information Ewing’s sarcoma recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VRDN-003 Treprostinil OXYBUTYNIN HYDROCHLORIDE Tomligisiran Incb000928 IDOR-1117-2520C Valoctocogene Roxaparvovec BNT327 Calcitriol SGT-003 LY3537031 Pemetrexed Disodium Jnj-77242113 Autogene Cevumeran C1 Esterase Inhibitor (Human) Sucrose Ripretinib Neflamapimod Treg02 Eftilagimod Alfa More therapies…

    Learn about Your Condition

    Obesity Relapsing multiple sclerosis Procedural pain Oedema peripheral Arginase deficiency Adenomyosis Mitral valve incompetence Coagulopathy Transitional cell carcinoma Rasmussen encephalitis Post-acute COVID-19 syndrome Spondylolisthesis Aortic valve disease Laryngeal leukoplakia Juvenile psoriatic arthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A Study of Oxytocin Nasal Spray to Reduce Psychological Stress in Women Who Have Recovered from Breast Cancer

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Stress
    • Breast cancer female
    Investigated Drugs:
    • Oxytocin
    Belgium

  • Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    • Lupus nephritis
    Investigated Drugs:
    • Fludarabine
    • CC-97540
    • Fludarabine Phosphate
    Austria Belgium Denmark France Germany Italy +3

  • Evaluation of opioid use with nociceptive monitoring in intensive care patients receiving deep sedation with isoflurane, propofol, and midazolam

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Isoflurane
    • Propofol
    Spain

  • Study of Anakinra compared to placebo for treating acute myocarditis in children admitted to intensive care units

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Myocarditis
    Investigated Drugs:
    • Anakinra
    • Sodium Chloride
    France

  • Study of early dapagliflozin treatment to reduce heart damage in patients with acute heart attack and reduced heart pumping function

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Dapagliflozin
    Italy

  • Study of safinamide compared to placebo for pain relief in patients with Parkinson’s disease who experience motor fluctuations

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Safinamide
    Italy
Previous Page
1 … 772 773 774 775 776 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!